CompanyGraph
At a glance
- Depends onDownstream position: depends on 10 industries, supplies 5
- ScaleLevered free cash flow is -$289.25M, lower than 95% of all stocks globally
- FinancialsAltman Z-Score 2.62: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
13.79BCNY2.06B · vs all stocks (USD)
Revenue (TTM)
2.77BCNY412.64M · vs all stocks (USD)
Profit Margin
-7.95%Beta
0.4410xvs all stocks
52-Week Change
9.79%vs all stocks
Market Capitalization
13.79BCNY2.06B · vs all stocks (USD)
Enterprise Value
17.58BCNY2.62B · vs all stocks (USD)
Forward P/E
-41.76xPrice to Sales (TTM)
4.99xPrice to Book (MRQ)
2.44xEnterprise to Revenue
6.36xEnterprise to EBITDA
52.55xGross Margin
35.33%Profit Margin
-7.95%Operating Margin
-4.93%Return on Assets (TTM)
-1.10%Return on Equity (TTM)
-3.57%Revenue (TTM)
2.77BCNY412.64M · vs all stocks (USD)
Revenue per Share (TTM)
2.39CNYUpdated Sep 20, 2026Quarterly Revenue Growth
25.30%Gross Profit (TTM)
693.36MCNY103.46M · vs all stocks (USD)
EBITDA (TTM)
414.37MCNY61.83M · vs all stocks (USD)
Net Income (TTM)
-219.87MCNY-32.81M · vs all stocks (USD)
Operating Cash Flow (TTM)
523.85MCNY78.17M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-1.94BCNY-289.25M · vs all stocks (USD)
Payout Ratio
0.00%Minority Interest (Equity)
39.36MCNYFY2025 · Dec 31, 2025Revenue
2.61BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
1.94BCNYFY2025 · Dec 31, 2025Gross Profit
664.17MCNYFY2025 · Dec 31, 2025Operating Income
-129.67MCNY-19.35M · vs all stocks (USD)
Pre-tax Income
-207.82MCNYFY2025 · Dec 31, 2025Income Tax Expense
23.01MCNYFY2025 · Dec 31, 2025Net Income
-230.82MCNYFY2025 · Dec 31, 2025EBIT
-158.81MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
414.37MCNYFY2025 · Dec 31, 2025Research & Development
579.82MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
104.92MCNYFY2025 · Dec 31, 2025Other Operating Expenses
17.14MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
5.06MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
49.01MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.1900CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.1900CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
1.15BSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
1.15BSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-230.82MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
11.46MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-21.36MCNYFY2025 · Dec 31, 2025Free Cash Flow
-1.81BCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.01BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-230.82MCNYFY2025 · Dec 31, 2025Other Non-cash Items
50.71MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
284.67MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-125.91MCNYFY2025 · Dec 31, 2025Capital Expenditures
-1.79BCNYFY2025 · Dec 31, 2025Net Acquisitions
-30.11MCNYFY2025 · Dec 31, 2025Purchase of Investments
-23.00MCNYFY2025 · Dec 31, 2025Sale of Investments
65.07MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-1.78BCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
2.65BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-1.33BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-53.21MCNYFY2025 · Dec 31, 2025Other Financing Charges
133.70MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
1.40BCNYFY2025 · Dec 31, 2025Shares Outstanding
1.14BSharesUpdated Sep 20, 2026Float Shares
847.72MSharesUpdated Sep 20, 2026% Held by Insiders
27.45%vs all stocks
% Held by Institutions
2.86%vs all stocks
Total Cash (MRQ)
828.47MCNY123.62M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.7280CNYUpdated Sep 20, 2026Total Debt (MRQ)
4.56BCNY680.13M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.7982xCurrent Ratio (MRQ)
1.95xBook Value per Share (MRQ)
4.97CNYUpdated Sep 20, 2026Total Assets
9.94BCNY1.48B · vs all stocks (USD)
Total Current Assets
3.76BCNYFY2025 · Dec 31, 2025Total Liabilities
4.17BCNYFY2025 · Dec 31, 2025Total Non-current Assets
6.18BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
2.01BCNYFY2025 · Dec 31, 2025Total Current Liabilities
2.16BCNYFY2025 · Dec 31, 2025Cash
1.01BCNYFY2025 · Dec 31, 2025Cash Equivalents
51.24MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.06BCNYFY2025 · Dec 31, 2025Accounts Receivable
1.08BCNYFY2025 · Dec 31, 2025Inventory
981.19MCNYFY2025 · Dec 31, 2025Accounts Payable
544.12MCNYFY2025 · Dec 31, 2025Short-term Debt
1.11BCNYFY2025 · Dec 31, 2025Other Current Liabilities
22.86MCNYFY2025 · Dec 31, 2025Long-term Debt
1.89BCNYFY2025 · Dec 31, 2025Common Stock (Book)
1.14BCNYFY2025 · Dec 31, 2025Retained Earnings
1.67BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
5.77BCNY860.92M · vs all stocks (USD)
52-Week Low
9.39CNYUpdated Sep 20, 202652-Week High
22.12CNYUpdated Sep 20, 202652-Week Change
9.79%vs all stocks
Beta
0.4410xvs all stocks
50-Day MA
13.22CNYUpdated Sep 20, 2026200-Day MA
14.08CNYUpdated Sep 20, 2026Avg 10-Day Volume
23.42MSharesUpdated Sep 20, 2026Avg 30-Day Volume
38.06MSharesUpdated Sep 20, 2026Diluted EPS (TTM)
-0.1900CNYUpdated Sep 20, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 2.62: safe zoneNotable
Altman Z-Score: 2.62
Supply Chain
Downstream position: depends on 10 industries, supplies 5Notable
Outgoing: 5.00Incoming: 10.00
High connectivity hub: 15 industry connectionsNotable
Total Connections: 15.00
Scale
Levered free cash flow is -$289.25M, lower than 95% of all stocks globallySignificant
Levered free cash flow (USD): -289,251,237.727Global P5: -202,685,365.334
Market cap is $2.06B, above the global median of $1.18BNotable
Market cap (USD): 2,057,775,286.614Global Median: 1,180,223,658.953
Companies that share the same coordination system — how they create, deliver, or capture value.
nCino, Inc.
Tier 1ProductionRecurring-Revenue Lock-InFlowRisk
Calix Inc.
Tier 1ProductionRecurring-Revenue Lock-InFlowInterface
Justsystems Corporation
Tier 1ProductionRecurring-Revenue Lock-InSenseMakingInterface
UCloud Technology Co., Ltd.
Tier 1ProductionRecurring-Revenue Lock-InFlowInterface
Blackbaud Inc.
Tier 1ProductionRecurring-Revenue Lock-InSenseMakingInterface
Winning Health Technology Group Co., Ltd.
Tier 1ProductionRecurring-Revenue Lock-InFlowRule
Aisino Corporation
Tier 1ProductionRecurring-Revenue Lock-InFlowRule
Linius Technologies Limited
Tier 1ProductionRecurring-Revenue Lock-InFlowSenseMaking
A10 Networks, Inc.
Tier 1ProductionRecurring-Revenue Lock-InFlowRule
Vertex Inc.
Tier 1ProductionRecurring-Revenue Lock-InRuleSenseMaking
Companies that share active interpretations — structural patterns currently present in both stocks.
Abivax SA
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
ADC Therapeutics S.A.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Ifishdeco Tbk PT
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated